Company Name | Actelion |
---|---|
Website | https://en.wikipedia.org |
Snippet | WebActelion is a pharmaceuticals and biotechnology company established in December 1997, headquartered in Allschwil near Basel, Switzerland. [2] Actelion focuses on the manufacture of drugs that treat rare and orphan diseases. Some of the drugs it has produced have been used to treat patients with symptoms related to central nervous system ... |
Type | public company |
Parent | Johnson & Johnson |
Founded | 1997 |
Founder | Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann |
Revenue | CHF 2.412 billion (2016)[1] |
Website | actelion.com |
Industry | Pharmaceuticals/Biotech |
Products | Tracleer, Ventavis, Zavesca, Veletri, Opsumit |
Key people | Jean-Paul Clozel(CEO) |
Area served | Research and Development of medicines for unmet medical need |
Headquarters | Gewerbestrasse 16, Allschwil, Basel, Switzerland |
Operating income | CHF 992 million (2016) |
Number of employees | 2,624 (2016) |
Actelion is part of the Switzerland company list
Have a list of company names and need to update information? Use our Company Search tool.
Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.
Want to update this profile? Please contact us here with a link to the public source verifying the edit.
Powrbot Inc. is a passionate company working on problems using data analytics, automation & machine learning. Our goal is to automate the boring stuff.
Contact Us